Homepage
Greater London
Greater London Legal Chronicle
Iksuda Therapeutics’ £29.6 Million Series A Financing Round

Iksuda Therapeutics’ £29.6 Million Series A Financing Round

June 9, 2021 Giulia Di Palma Greater London, Greater London Legal Chronicle

Tagged: Andrew Rink Ashfords LLP Bird & Bird Celltrion Healthcare Charles Davies Iksuda Therapeutics James Baillieu Jocelyn Ormond Katie Tyndall Mark Lomas Mirae Asset Securities (HK) Limited Nicola Manclark Pieter Erasmus Premier Partners Richie Lamb Sally Shorthose Scott Preece Simon Gough Vanessa James

In UK Ashfords LLP, Bird & Bird, advised on the matter.Ashfords LLP advised Iksuda Therapeutics with a team including Vanessa James (Human Capital), Mark Lomas (IP&IT),…

This content is for members only.
Join Now

Already a member? Log in here

The BE Company’s Acquisition of CloudCoCo Connect

Clear London Markets Limited’s Acquisition of Lilley Plummer Holdings Limited

Kinetico’s Acquisition of Good Health Centre and The Waldegrave Clinic

Globeducate’s Acquisition of L’Ecole des Petits

Oddlygood’s Acquisition of Rude Health

Houlihan Lokey’s Acquisition of Prytania Solutions

Robert P. Slight & Sons’ Sale to EOT

Connelly Group Holdings’ Acquisition of Scottish Security & Fire Systems

McKinlay Kidd’s Sale To An Employee Ownership Trust

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

McDermott Strengthens Global Private Equity Offering With New Hire in London

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

McDermott Continues Its Accelerated Growth in London With Senior Tax Hire

Iksuda Therapeutics’ £29.6 Million Series A Financing Round

Author: Giulia Di Palma